| Registered number: 8879832 | ||||||||
| FOR THE 456 DAY PERIOD ENDED 31/03/2025 | ||||||||
| Prepared By: | ||||||||
| Staffer Mayled & Co Limited | ||||||||
| 46-48 | ||||||||
| Station Road | ||||||||
| Llanishen | ||||||||
| Cardiff | ||||||||
| CF14 5LU | ||||||||
| Chase Healthcare Limited | ||||||||
| ACCOUNTS | ||||||||
| FOR THE 456 DAY PERIOD ENDED 31/03/2025 | ||||||||
| DIRECTORS | ||||||||
| SECRETARY | ||||||||
| REGISTERED OFFICE | ||||||||
| COMPANY DETAILS | ||||||||
| Private company limited by shares registered in EW - England and Wales, registered number 8879832 | ||||||||
| ACCOUNTANTS | ||||||||
| Staffer Mayled & Co Limited | ||||||||
| 46-48 | ||||||||
| Station Road | ||||||||
| Llanishen | ||||||||
| Cardiff | ||||||||
| CF14 5LU | ||||||||
| Chase Healthcare Limited | ||||||||
| ACCOUNTS | ||||||||
| FOR THE456 DAY PERIODENDED31/03/2025 | ||||||||
| CONTENTS | ||||||||
| Page | ||||||||
| Directors' Report | - | |||||||
| Accountants' Report | - | |||||||
| Statement Of Comprehensive Income | - | |||||||
| Balance Sheet | 3 | |||||||
| Notes To The Accounts | 4 | |||||||
| The following do not form part of the statutory financial statements: | ||||||||
| Trading And Profit And Loss Account | - | |||||||
| Profit And Loss Account Summaries | - | |||||||
| Chase Healthcare Limited | ||||||||
| BALANCE SHEET AT | ||||||||||
| 2025 | 2024 | |||||||||
| Notes | £ | £ | ||||||||
| FIXED ASSETS | ||||||||||
| Tangible assets | 3 | |||||||||
| Investment Assets | 4 | |||||||||
| CURRENT ASSETS | ||||||||||
| Debtors | 5 | |||||||||
| Cash at bank and in hand | ||||||||||
| 272,508 | 332,307 | |||||||||
| CREDITORS: Amounts falling due within one year | 6 | |||||||||
| NET CURRENT ASSETS | 216,909 | |||||||||
| TOTAL ASSETS LESS CURRENT LIABILITIES | ||||||||||
| CREDITORS: Amounts falling due after more than one year | 7 | 487,771 | - | |||||||
| PROVISIONS FOR LIABILITIES AND CHARGES | 8 | |||||||||
| NET ASSETS | ||||||||||
| CAPITAL AND RESERVES | ||||||||||
| Called up share capital | 9 | |||||||||
| Profit and loss account | 993,075 | 656,843 | ||||||||
| SHAREHOLDERS' FUNDS | ||||||||||
| Approved by the board on | ||||||||||
| ............................. | ||||||||||
| Director | ||||||||||
| Chase Healthcare Limited | ||||||||
| NOTES TO THE ACCOUNTS | ||||||||||
| FOR THE 456 DAY PERIOD ENDED 31/03/2025 | ||||||||||
| 1. ACCOUNTING POLICIES |
| 1a. Basis Of Accounting | ||||||||
| The accounts have been prepared under the historical cost convention. | ||||||||
| The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 . | ||||||||
| 1b. Depreciation | ||||||||
| Land And Buildings | reducing balance 2% | |||||||
| Plant and Machinery | reducing balance 25% | |||||||
| 1c. Pension Costs | ||||||||
| The company operates a defined contribution pension scheme. The pension charge represents the amounts payable by the company to the fund in respect of the year. | ||||||||
| 1d. Investments | ||||||||
| Fixed asset investments are shown at cost less amounts written off. | ||||||||
| Provisions are made for permanent fluctuations in value. | ||||||||
| 2. EMPLOYEES | ||||||
| 2025 | 2024 | |||||
| No. | No. | |||||
| Average number of employees | - | |||||
| Chase Healthcare Limited | ||||||||
| 3. TANGIBLE FIXED ASSETS | ||||||
| Land And | Plant and | |||||
| Buildings | Machinery | Total | ||||
| £ | £ | £ | ||||
| Cost | ||||||
| At 01/01/2024 | 175,000 | 7,741 | 182,741 | |||
| Additions | 197,344 | 41,018 | 238,362 | |||
| At 31/03/2025 | 372,344 | 48,759 | 421,103 | |||
| Depreciation | ||||||
| At 01/01/2024 | 25,667 | 4,080 | 29,747 | |||
| For the 456 day period | 3,500 | 11,172 | 14,672 | |||
| At 31/03/2025 | 29,167 | 15,252 | 44,419 | |||
| Net Book Amounts | ||||||
| At 31/03/2025 | 376,684 | |||||
| At 31/12/2023 | 152,994 | |||||
| 4. FINANCIAL ASSETS | |||||||||
| Shares in group companies | |||||||||
| and participating interests | Total | ||||||||
| £ | £ | ||||||||
| Cost | |||||||||
| At 01/01/2024 | 287,044 | 287,044 | |||||||
| Additions | 686,836 | 686,836 | |||||||
| At 31/03/2025 | 973,880 | 973,880 | |||||||
| Amortisation | |||||||||
| Net Book Amounts | |||||||||
| At 31/03/2025 | 973,880 | 973,880 | |||||||
| At 31/12/2023 | 287,044 | 287,044 | |||||||
| 5. DEBTORS | 2025 | 2024 | ||||||
| £ | £ | |||||||
| Amounts falling due within one year | ||||||||
| Trade debtors | 55,893 | 37,687 | ||||||
| 55,893 | 37,687 | |||||||
| Chase Healthcare Limited | ||||||||
| 6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | ||||||||
| 2025 | 2024 | |||||||
| £ | £ | |||||||
| UK corporation tax | 20,031 | 38,065 | ||||||
| PAYE control | 2,275 | - | ||||||
| Directors current account | 43,342 | 5,089 | ||||||
| Trade creditors | 51,014 | 32,467 | ||||||
| Amounts due to group companies | 19,482 | 39,777 | ||||||
| 136,144 | 115,398 | |||||||
| 7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR | ||||||||
| 2025 | 2024 | |||||||
| £ | £ | |||||||
| Loans >1yr | 453,019 | - | ||||||
| Hire purchase >1yr | 34,752 | - | ||||||
| 487,771 | - | |||||||
| 8. PROVISIONS FOR LIABILITIES | 2025 | 2024 | ||||||
| £ | £ | |||||||
| Deferred taxation | 5,978 | - | ||||||
| 5,978 | - | |||||||
| Chase Healthcare Limited | ||||||||
| 9. SHARE CAPITAL | 2025 | 2024 | ||||||
| £ | £ | |||||||
| Allotted, issued and fully paid: | ||||||||
| 100 | 100 | |||||||
| 1 | 1 | |||||||
| 1 | 1 | |||||||
| 1 | 1 | |||||||
| 1 | 1 | |||||||
| 104 | 104 | |||||||
| New shares issued during period: | ||||||||
| | 1 | |||||||
| | 1 | |||||||
| | 1 | |||||||
| | 1 | |||||||
| - | 4 | |||||||
| 10. CONTROLLING PARTY | ||||||||
| Are the directors and shareholders of the company. | ||||||||